Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 3, 2025

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.7K

[Diffuse midline glioma].

Ryuta Saito1

  • 1Department of Neurosurgery, Nagoya University, Graduate School of Medicine.

No Shinkei Geka. Neurological Surgery
|February 16, 2022
PubMed
Summary

Diffuse midline glioma (DMG), a K27M-mutant brain tumor, has a poor prognosis despite extensive research. Current treatments are limited, highlighting the need for effective precision medicine strategies targeting DMG.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum Computing Calculations of Protein-Ligand Binding Energies Using Decomposition Methods on Simulated and Real Quantum Hardware.

Journal of chemical information and modeling·2026
Same author

Dynamic Tumor Volume Changes after Debulking Surgery of Optic Hypothalamus Pilocytic Astrocytoma.

Neurologia medico-chirurgica·2026
Same author

Dominant T cell receptor clonotypes in adrenocorticotropic hormone-secreting pituitary carcinoma are the highest-frequency clones among CD4<sup>+</sup> and CD8<sup>+</sup> cells in peripheral blood during effective anti-PD-1 therapy.

Frontiers in immunology·2026
Same author

Possible involvement of genome-wide near-haploidy and <i>MEN1</i> mutation in the molecular pathogenesis of pituitary carcinoma: Analysis by whole exome sequencing.

Neuro-oncology advances·2026
Same author

Physiological biodistribution of <sup>18</sup>F-fluciclovine PET in the head: as a baseline for interpretation in patients with suspected glioma.

Frontiers in nuclear medicine·2026
Same author

A multicenter randomized phase II/III trial of salvage treatment for refractory primary central nervous system lymphoma using tirabrutinib: JCOG2314 (ReSTART).

Japanese journal of clinical oncology·2026

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Molecular pathology

Background:

  • Diffuse midline glioma (DMG), H3 K27M-mutant, is an aggressive, infiltrative brain tumor predominantly affecting children.
  • Commonly found in the brainstem (as diffuse intrinsic pontine glioma - DIPG), thalamus, and spinal cord, DMG has a dismal prognosis with a 2-year survival rate below 10%.

Purpose of the Study:

  • To review the current understanding of diffuse midline glioma (DMG), H3 K27M-mutant.
  • To highlight the challenges and future directions in developing effective precision medicine for DMG.

Main Methods:

  • Review of scientific literature on DMG genetics, treatment, and clinical trials.
  • Analysis of the efficacy of molecular targeted therapies and challenges in blood-brain barrier penetration.

Main Results:

  • DMG is characterized by the H3 K27M mutation, present in ~80% of DIPG cases.
  • Despite numerous clinical trials (~250) investigating molecular targeted therapies, none have demonstrated significant efficacy.
  • A key challenge is the limited understanding of blood-brain barrier penetration for targeted agents.

Conclusions:

  • Radiation therapy remains the primary treatment for DMG, with no effective chemotherapeutic options currently available.
  • Further research into precision medicine, addressing challenges like drug delivery across the blood-brain barrier, is crucial for improving outcomes in DMG.

More Related Videos

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

599
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.8K

Related Experiment Videos

Last Updated: Oct 3, 2025

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.7K
A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

599
Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
09:53

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery

Published on: July 5, 2021

3.8K